MPM BioImpact LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,221,485
-22.5%
544,6390.0%4.60%
+2.8%
Q2 2023$22,210,378
+4.1%
544,639
-4.9%
4.47%
-19.3%
Q1 2023$21,335,547
+34.3%
572,459
+25.7%
5.54%
+34.5%
Q4 2022$15,883,254
-24.2%
455,238
+21.6%
4.12%
-16.9%
Q3 2022$20,952,000
+35.2%
374,409
+25.0%
4.96%
+15.3%
Q2 2022$15,497,000
+33.8%
299,409
+87.8%
4.30%
+38.5%
Q1 2022$11,584,000
-39.0%
159,409
-0.7%
3.11%
-10.1%
Q4 2021$18,981,000
-13.0%
160,527
-1.3%
3.46%
+2.2%
Q3 2021$21,815,000
+212.9%
162,620
+26.9%
3.38%
+462.1%
Q4 2020$6,972,000128,1620.60%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders